Cargando…
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
BACKGROUND: Papillomas of the breast pose challenges for treatment decisions as their risk for transformation to breast cancer is low but not negligible. To spare low-risk patients the burden of substantial treatment side effects, prognostic indicators are needed for cancerous progression. The secre...
Autores principales: | Ziółkowski, Piotr, Woźniak, Marta, Mansour, Ahmad, An, Yu, Weber, Georg F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520814/ https://www.ncbi.nlm.nih.gov/pubmed/36175970 http://dx.doi.org/10.1186/s13058-022-01561-9 |
Ejemplares similares
-
Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
por: Walaszek, Kinga, et al.
Publicado: (2018) -
Osteopontin splice variants are differential predictors of breast cancer treatment responses
por: Zduniak, Krzysztof, et al.
Publicado: (2016) -
Meta-analysis of Osteopontin splice variants in cancer
por: An, Yu, et al.
Publicado: (2023) -
RNA blood levels of osteopontin splice variants are cancer markers
por: Hartung, Franz, et al.
Publicado: (2013) -
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
por: Kamalabadi-Farahani, Mohammad, et al.
Publicado: (2022)